Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
H Bulus, S Oguztuzun, G Güler Simsek, M Kilic, A Oguz Ada, S Göl, A Kaya Kocdogan, P Kaygın, B Bozer & M Iscan. (2019) Expression of CYP and GST in human normal and colon tumor tissues. Biotechnic & Histochemistry 94:1, pages 1-9.
Read now
Read now
DAVID J. WAXMAN, LING CHEN, JODI E. D. HECHT & YOUSSEF JOUNAIDI. (1999) CYTOCHROME P450-BASED CANCER GENE THERAPY: RECENT ADVANCES AND FUTURE PROSPECTS. Drug Metabolism Reviews 31:2, pages 503-522.
Read now
Read now
Johannes Everse. (1997) Bioactivation of Chemotherapeutic Agents. Emerging Therapeutic Targets 1:1, pages 147-149.
Read now
Read now
Yu Shao, Lani Pardini & RonaldS. Pardini. (1997) Intervention of transplantable human mammary carcinoma MX‐1 chemotherapy with dietary menhaden oil in athymic mice: Increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutrition and Cancer 28:1, pages 63-73.
Read now
Read now
R. L. H. Cheung, C. Lee, E. J. Jones & D. S. Riddick. (1996) Lack of effect of methotrexate on the expression of constitutive hepatic cytochromes P450 in the male rat. Xenobiotica 26:5, pages 503-514.
Read now
Read now
Abdulaziz A. Al-Jafari, Mohammad Amjad Kamal & Ali S. Duhaiman. (1995) The Mode of Inhibition of Human Erythrocyte Membrane-Bound Acetylcholinesterase by Cisplatin in Vitro. Journal of Enzyme Inhibition 8:4, pages 281-289.
Read now
Read now
Articles from other publishers (33)
Thoria Diab, Samar Sami AlKafaas, Thanaa Ibrahim Shalaby & Mohamed Hessien. (2020) Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells. Bioorganic Chemistry 99, pages 103792.
Crossref
Crossref
Saba Hadidi, Farshad Shiri & Mohammadsaleh Norouzibazaz. (2019) A DFT study of the degradation mechanism of anticancer drug carmustine in an aqueous medium. Structural Chemistry 30:4, pages 1315-1321.
Crossref
Crossref
Farshad Shiri, Mohammadsaleh Norouzibazaz, Ako Yari & Avat Taherpour. (2018) A DFT study of both the hydrolytic degradation and protonation of semustine in variation conditions of pH and interaction of drug with DNA nucleobases. Structural Chemistry 29:5, pages 1465-1474.
Crossref
Crossref
Jessica K Campbell, Chad K Stroud, Manabu T Nakamura, Mary Ann Lila & John W ErdmanJrJr. (2006) Serum Testosterone Is Reduced Following Short-Term Phytofluene, Lycopene, or Tomato Powder Consumption in F344 Rats. The Journal of Nutrition 136:11, pages 2813-2819.
Crossref
Crossref
Johannes Lengler, Markus Omann, Dana Düvier, Harry Holzmüller, Wolfgang Gregor, Brian Salmons, Walter H. Günzburg & Matthias Renner. (2006) Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy. Biochemical Pharmacology 72:7, pages 893-901.
Crossref
Crossref
E Ferruzzi, R Franceschini, G Cazzolato, C Geroni, C Fowst, U Pastorino, N Tradati, J Tursi, R Dittadi & M Gion. (2003) Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck. European Journal of Cancer 39:7, pages 1019-1029.
Crossref
Crossref
Alex Baldwin, Zeqi Huang, Youssef Jounaidi & David J Waxman. (2003) Identification of novel enzyme–prodrug combinations for use in cytochrome P450-based gene therapy for cancer. Archives of Biochemistry and Biophysics 409:1, pages 197-206.
Crossref
Crossref
Juris Germanas & Amit G. Pandya. (2002) Alkylating agents. Dermatologic Therapy 15:4, pages 317-324.
Crossref
Crossref
Morag C.E McFadyen, Howard L McLeod, Fiona C Jackson, William T Melvin, Johannes Doehmer & Graeme I Murray. (2001) Cytochrome P450 CYP1B1 protein expression:. Biochemical Pharmacology 62:2, pages 207-212.
Crossref
Crossref
Zeqi Huang & David J Waxman. (2001) Modulation of cyclophosphamide-based cytochrome P 450 gene therapy using liver P450 inhibitors. Cancer Gene Therapy 8:6, pages 450-458.
Crossref
Crossref
Johnny Di Re, Chunja Lee & David S Riddick. (1999) Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin. Canadian Journal of Physiology and Pharmacology 77:8, pages 589-597.
Crossref
Crossref
Lance P. Encell, Daniel M. Landis & Lawrence A. Loeb. (1999) Improving enzymes for cancer gene therapy. Nature Biotechnology 17:2, pages 143-147.
Crossref
Crossref
Julia A Hasler, Ronald Estabrook, Michael Murray, Irina Pikuleva, Michael Waterman, Jorge Capdevila, Vijakumar Holla, Christian Helvig, John R Falck, Geoffrey Farrell, Laurence S Kaminsky, Simon D Spivack, Eric Boitier & Philippe Beaune. (1999) Human cytochromes P450. Molecular Aspects of Medicine 20:1-2, pages 1-137.
Crossref
Crossref
Abdulaziz A Al-Jafari, Fareeda Al-Khwyter & Mohammad A Kamal. (1998) Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin. Cancer Letters 128:1, pages 79-86.
Crossref
Crossref
G. Freyer, B. Ligneau, B. Tranchand, C. Ardiet, F. Serre-Debeauvais & V. Trillet-Lenoir. (1997) Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice. Cancer Treatment Reviews 23:3, pages 153-169.
Crossref
Crossref
P.J.M. Sessink, W.H.J. Vaes, P.H.H. van den Broek, J.H.C. de Roos, J. Noordhoek & R.P. Bos. (1996) Influence of Aroclor 1254, phenobarbital, β-naphthoflavone, and ethanol pretreatment on the biotransformation of cyclophosphamide in male and female rats. Toxicology 112:2, pages 141-150.
Crossref
Crossref
A. Rubagotti, A. Perrotta, C. Casella & F. Boccardo. (1996) Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer. Annals of Oncology 7:3, pages 239-244.
Crossref
Crossref
Armaghan Afsar, Chunja Lee & David S Riddick. (1996) Modulation of the expression of constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil. Canadian Journal of Physiology and Pharmacology 74:2, pages 150-156.
Crossref
Crossref
Abdulaziz A. Al-Jafari, Fareeda Al-Khwyter, Mohammad A. Kamal & Abdullah S. Alhomida. (1996) Kinetics for Camel (Camelus dromedarius) Retina Acetylcholinesterase Inhibition by Methotrexate In Vitro. Japanese Journal of Pharmacology 72:1, pages 49-55.
Crossref
Crossref
Philip G. Penketh, Krishnamurthy Shyam & Alan C. Sartorelli. 1996. Drug Resistance. Drug Resistance
65
81
.
Graeme I. Murray, Valerie E. Taylor, Judith A. McKay, Richard J. Weaver, Stanley W. B. Ewen, William T. Melvin & M. Danny Burke. (2005) The immunohistochemical localization of drug‐metabolizing enzymes in prostate cancer. The Journal of Pathology 177:2, pages 147-152.
Crossref
Crossref
Diana Anderson, Jack B. Bishop, R.Colin Garner, Patricia Ostrosky-Wegman & Paul B. Selby. (1995) Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 330:1-2, pages 115-181.
Crossref
Crossref
Ming X. Wei, Takashi Tamiya, Xandra O. Breakefield & E. Antonio Chiocca. 1995. Viral Vectors. Viral Vectors
239
257
.
Ming X. Wei, Takashi Tamiya, Maureen Chase, Efstathios J. Boviatsis, Thomas K. H. Chang, Neil W. Kowall, Fred H. Hochberg, David J. Waxman, Xandra O. Breakefield & E. Antonio Chiocca. (1994) Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene. Human Gene Therapy 5:8, pages 969-978.
Crossref
Crossref
G I Murray, D Shaw, R J Weaver, J A McKay, S W Ewen, W T Melvin & M D Burke. (1994) Cytochrome P450 expression in oesophageal cancer.. Gut 35:5, pages 599-603.
Crossref
Crossref
Johannes Doehmer, Arnold R. Goeptar & Nico P. E. Vermeulen. 1994. Multiple Drug Resistance in Cancer. Multiple Drug Resistance in Cancer
357
366
.
L. Chen & D. J. Waxman. 1994. Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research. Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research
57
80
.
Graeme I. Murray, Judith A. McKay, Richard J. Weaver, Stanley W. B. Ewen, William T. Melvin & M. Danny Burke. (2005) Cytochrome P450 expression is a common molecular event in soft tissue sarcomas. The Journal of Pathology 171:1, pages 49-52.
Crossref
Crossref
Georg F. Weber & David J. Waxman. (1993) Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes. Biochemical Pharmacology 45:8, pages 1685-1694.
Crossref
Crossref
Graeme I. Murray, Richard J. Weaver, Pamela J. Paterson, Stanley W. B. Ewen, William T. Melvin & M. Burke Danny. (2005) Expression of xenobiotic metabolizing enzymes in breast cancer. The Journal of Pathology 169:3, pages 347-353.
Crossref
Crossref
Johannes Doehmer, Arnold R. Goeptar & Nico P. E. Vermeulen. (1993) Cytochromes P450 and drug resistance. Cytotechnology 12:1-3, pages 357-366.
Crossref
Crossref
Sandra Kuzmich & Kenneth D. Tew. (1991) Detoxification Mechanisms and Tumor Cell Resistance to Anticancer Drugs. Medicinal Research Reviews 11:2, pages 185-217.
Crossref
Crossref
Hans-Pietro Eugster, Christian Sengstag, Urs A. Meyer, Albert Hinnen & Friedrich E. W?rgler. (1990) Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: An alternative enzyme source for in vitro studies. Biochemical and Biophysical Research Communications 172:2, pages 737-744.
Crossref
Crossref